Atlas Trials

TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors

Clinical trial NCT03079440 · COMPLETED

Trial details

NCT number
NCT03079440
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine TumorsNeuroendocrine CarcinomaTemozolomideCapecitabine
Start date
2017-05-15
Primary completion
2020-11-15
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.